Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.


Player Avatar pchop123 (80.22) Submitted: 12/23/2012 10:37:06 PM : Outperform Start Price: $49.01 LLY Score: +5.14

solid bran with PE just over 13 & 4% div yield

Featured Broker Partners